BofA lowers its price target on Pfizer (PFE) to $26 from $27

Pfizer Inc. (NYSE:PFE) is one of the 8 Cheap Large Cap Stocks to Buy Now. On April 9, 2026, BofA lowered the price target on ...

Guggenheim Sees Favorable Risk-Reward for Pfizer (PFE) Ahead of Phase 3 Data

Pfizer Inc. (NYSE:PFE) is included among the Dividend Stock Portfolio for Income: 15 Stocks to Invest In. On March 24, Guggenheim Partners raised its price recommendation on Pfizer Inc. (NYSE:PFE) to ...
Zacks Investment Research on MSN

Pfizer (PFE) stock drops despite market gains: Important facts to note

Pfizer (PFE) closed at $27.10 in the latest trading session, marking a -2.62% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 0.08%. Meanwhile, the Dow ...
Forbes

What’s Behind The Slump In Pfizer Stock?

Pfizer stock (NYSE: PFE) is currently in a significant slump, marking its ninth consecutive day of decline and losing a total of −11% of its value over that period. This sustained sell-off has wiped ...
Insider Monkey

Is Pfizer Inc. (PFE) One of Goldman Sachs Top Healthcare Stocks?

Pfizer Inc. (NYSE:PFE) is one of Goldman Sachs top healthcare stocks. On March 9, analysts at BMO reiterated an Outperform rating on Pfizer Inc. (NYSE:PFE) and a $30 price target. The bullish stance ...
AOL

Pfizer Could Hit $36 by Year-End as Analysts See 2-to-1 Payoff on Key Prostate Cancer Trial

Tue, March 24, 2026 at 2:52 PM UTC Pfizer (NYSE:PFE) has quietly built momentum in 2026, with shares up 6.61% year-to-date and 2.70% over the past year. The stock is currently trading near $26.84 but ...